Background To eliminate cervical cancer as a public health problem, the World Health
Organization had recommended routine vaccination of adolescent girls with two doses of the …

Summary Background The WHO Strategic Advisory Group of Experts recommended that an
extended interval of 3–5 years between the two doses of the human papillomavirus (HPV) …

Up to 2016, low‐and middle‐income countries mostly introduced routine human
papillomavirus (HPV) vaccination for just a single age‐cohort of girls each year. However …

Background Two-dose human papillomavirus (HPV) vaccine schedules may provide short-
term protection but their long-term population impact is unknown. Methods Two models of …

Background Given the accumulating evidence that one-dose vaccination could provide high
and sustained protection against human papillomavirus (HPV) infection and related …

Background Despite the high burden of cervical cancer, access to preventive measures
remains low in India. A single-dose immunisation schedule could facilitate the scale-up of …

Background Introduction of human papillomavirus (HPV) vaccination has been slow in low-
income and middle-income countries (LMICs) because of resource constraints and …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …

Background Recent evidence suggests that two doses of HPV vaccines may be as
protective as three doses in the short-term. We estimated the incremental cost-effectiveness …

Background Although guidelines for prophylactic human papillomavirus (HPV) vaccination
recommend two doses for girls ages 9–14 years, several studies have demonstrated similar …